Colgate-Palmolive Company (NYSE:CL) finished Wednesday with a subtraction of -$0.26 to close at $74.90, a downside of -0.35 percent. An average of 3,911,260 shares of common stock have been traded in the last five days. There was a fall of -$1.16 in the past week, and it reached a new high 22 times over the past 12 months. The last 20 days have seen an average of 4,275,580 shares traded, while the 50-day average volume stands at 4,326,420.
CL stock has decreased by -8.61% in the last month. The company shares reached their 1-month lowest point of $74.53 on 09/15/22. With the stock rallying to its 52-week high on 01/06/22, shares of the company touched a low of $72.20 and a high of $85.61 in 52 weeks. It has reached a new high 4 times so far this year and lost -12.23% or -$10.44 in price. In spite of this, the price is down -12.51% from the 52-week high.
Top 5 Cheap Stocks to Own Right Now
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now. .
9 days have passed since Colgate-Palmolive Company (CL) last reported insider trading activity. Massey Sally, who is Chief Human Resources Officer, most recently acquired $656 shares at $77.58 per share on Sep 13. In this transaction, the insider spent $50,890. Grp Pres, Growth & Strategy, Parameswaran Prabha, disposed of 48,778 shares at a price of $78.80 on Aug 29. The insider now owns more than $3,843,565 worth of shares. Prior to that, CLO and Secretary Daniels Jennifer went on to Sale 24,703 shares at $81.25 each on Aug 04. An amount of $2,007,176 was transacted.
Colgate-Palmolive Company (CL) has a trailing price-to-earnings (P/E) ratio of 32.49. The stock’s beta is 0.47. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 3.51, the price-to-book (PB) ratio at 374.50, and the price-to-cash flow ratio at 90.39.
The company has a payout ratio of 78.70%. The company’s most recent quarterly dividend payment was $0.47 a share, without any change from last year. Its latest increase dividend $0.02 reported on Thursday March 10 2022.
The quick ratio of Colgate-Palmolive Company for the three months ended June 29 was 0.70, and the current ratio was 1.20, indicating that the company is not able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 47.36 and a total debt to equity ratio of 47.54 for the quarter ending June 29. Its gross profit as reported stood at $10.38 billion compared to revenue of $17.42 billion.
For the three-month period that ended June 29, Colgate-Palmolive Company had $7.96 billion in total debt. In the quarter under review, the net income was up than the previous quarter. The company posted a net income of $603.0 million in the quarter, while revenues were shrunk -16.58%. The analyst consensus anticipated Colgate-Palmolive Company’s latest quarter earnings to come in at $0.71 per share, but it turned out to be $0.72, a 1.40% surprise. For the quarter, EBITDA amounted to $1.02 billion. Shareholders own equity worth $834.12 million.
From a technical analysis perspective, let’s take a brief look at Colgate-Palmolive Company (CL) price momentum. RSI 9-day as of the close on 21 September was 30.95%, suggesting the stock is Neutral, with historical volatility in this time frame at 18.49%.
As of today, CL’s price is $75.40 -1.53% or -$1.16 from its 5-day moving average. CL is currently trading -7.49% lower than its 20-day SMA and -7.78% lower than its 100-day SMA. However, the stock’s current price level is -4.35% below the SMA50 and -2.44% below the SMA200.
The stochastic %K and %D were 14.04% and 16.99%, respectively, and the average true range (ATR) was 1.39. With the 14-day stochastic at 6.28% and the average true range at 1.39, the RSI (14) stands at 34.76%. The stock has reached -0.69 on the 9-day MACD Oscillator while the 14-day reading was at -1.54.
Wells Fargo upgraded Colgate-Palmolive Company (NYSE: CL) to a an Equal weight rating in its most recent analyst report. Previously, the stock was rated as an Underweight. The consensus rating for Colgate-Palmolive Company (CL) among analysts is Overweight. According to current brokerage recommendations, 0 brokerage firms advise that investors sell CL, while 16 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 7 others rate it as a “buy”.
What is CL’s price target for the next 12 months?
Analysts predict a range of price targets between $68.00 and $91.00, with a median target of $82.00. Taking a look at these predictions, the average price target given by analysts for Colgate-Palmolive Company (CL) stock is $82.50.